ASX - By Stock
|
RAC |
Re:
Ann: Notification of cessation of securities - RAC
|
|
M@g123
|
62 |
16K |
18 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
62
|
16K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
M@g123
|
7 |
2.2K |
15 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
7
|
2.2K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Professor Erin Howden Joins Race Oncology SAB
|
|
M@g123
|
22 |
9.2K |
11 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
22
|
9.2K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
87 |
31K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
87
|
31K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
87 |
31K |
8 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
87
|
31K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
87 |
31K |
12 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
87
|
31K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
20K |
6.9M |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
87 |
31K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
87
|
31K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
5 |
01/03/24 |
01/03/24 |
General
|
10K
|
3.7M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
M@g123
|
54 |
12K |
15 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
54
|
12K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
20K |
6.9M |
7 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
4 |
19/02/24 |
19/02/24 |
General
|
10K
|
3.7M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
4 |
19/02/24 |
19/02/24 |
General
|
10K
|
3.7M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
8 |
22/01/24 |
22/01/24 |
General
|
10K
|
3.7M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
M@g123
|
413 |
113K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
413
|
113K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
M@g123
|
413 |
113K |
4 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
413
|
113K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: December 2023 Preclinical & Clinical Program Update
|
|
M@g123
|
66 |
20K |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
M@g123
|
2.8K |
978K |
18 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
2.8K
|
978K
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
19 |
18/12/23 |
18/12/23 |
General
|
10K
|
3.7M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
M@g123
|
113 |
25K |
25 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
113
|
25K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML data presented at ASH conference
|
|
M@g123
|
53 |
15K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
821 |
206K |
0 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
821
|
206K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
821 |
206K |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
821
|
206K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
821 |
206K |
3 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
821
|
206K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
821 |
206K |
2 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
821
|
206K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
120K |
6 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
120K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
120K |
3 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
508
|
120K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
120K |
11 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
508
|
120K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
6 |
01/12/23 |
01/12/23 |
General
|
10K
|
3.7M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
120K |
22 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
508
|
120K
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
8 |
30/11/23 |
30/11/23 |
General
|
10K
|
3.7M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
4 |
30/11/23 |
30/11/23 |
General
|
10K
|
3.7M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
22 |
30/11/23 |
30/11/23 |
General
|
10K
|
3.7M
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
6 |
25/11/23 |
25/11/23 |
General
|
10K
|
3.7M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
M@g123
|
226 |
53K |
16 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
53K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
M@g123
|
226 |
53K |
20 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
53K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
M@g123
|
1.6K |
570K |
12 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
1.6K
|
570K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
M@g123
|
134 |
56K |
5 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
134
|
56K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
M@g123
|
231 |
64K |
10 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
231
|
64K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
M@g123
|
227 |
82K |
4 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
227
|
82K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
M@g123
|
231 |
64K |
20 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
64K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
M@g123
|
101 |
20K |
11 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
20K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
M@g123
|
101 |
20K |
10 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
20K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
20K |
6.9M |
17 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
20K
|
6.9M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
M@g123
|
153 |
48K |
7 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
153
|
48K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
M@g123
|
153 |
48K |
27 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
153
|
48K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
M@g123
|
23 |
6.9K |
12 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
23
|
6.9K
|
12
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
8 |
01/11/23 |
01/11/23 |
General
|
10K
|
3.7M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
7 |
01/11/23 |
01/11/23 |
General
|
10K
|
3.7M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.7M |
5 |
01/11/23 |
01/11/23 |
General
|
10K
|
3.7M
|
5
|
|